Robin Gasiorowski

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 6

Top Topics

Acute Lymphoblastic Leukemia

Diffuse Large B Cell Lymphoma

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Internal medicine journal

This page only lists publications with an associated author ORCID identifier.

Publications

Catherine Thieblemont, Tycel Jovelle Phillips, Hervé Ghesquières, Chan Yoon Y Cheah, Michael Roost Clausen, David Cunningham, Young Rok Do, Tatyana Feldman, Robin Gasiorowski, Wojciech Jurczak, Tae Min Kim, David John Lewis, Marjolein van der Poel, Michelle Limei Poon, Mariana Cota Stirner, Nurgul Kilavuz, Christopher Chiu, Menghui Chen, Mariana Sacchi, Brian Elliott, Tahamtan Ahmadi, Martin Hutchings, Pieternella J Lugtenburg
Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Robin Gasiorowski, Judith Trotman
CAR-T for follicular lymphoma: are we good to go? Blood 140 (8) (2022)
Catherine Thieblemont, Tycel Jovelle Phillips, Hervé Ghesquières, Chan Yoon Y Cheah, Michael Roost Clausen, David Cunningham, Young Rok Do, Tatyana Feldman, Robin Gasiorowski, Wojciech Jurczak, Tae Min Kim, David John Lewis, Marjolein van der Poel, Michelle Limei Poon, Mariana Cota Stirner, Nurgul Kilavuz, Christopher Chiu, Menghui Chen, Mariana Sacchi, Brian Elliott, Tahamtan Ahmadi, Martin Hutchings, Pieternella J Lugtenburg
Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Jonathan Wong, Emily Gruber, Belinda Maher, Mark Waltham, Zahra Sabouri-Thompson, Ian Jong, Quinton Luong, Sidney Levy, Beena Kumar, Daniella Brasacchio, Wendy Jia, Joan So, Hugh Skinner, Alexander Lewis, Simon J Hogg, Stephin Vervoort, Carmen DiCorleto, Micheleine Uhe, Jeanette Gamgee, Stephen Samuel Opat, Gareth P Gregory, Galina Polekhina, John Reynolds, Eliza A Hawkes, Gajan Kailainathan, Robin Gasiorowski, Lev M Kats, Jake Shortt
Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma. Leukemia 36 (6) (2022)
Pier Luigi Luigi Zinzani, Radhakrishnan Ramchandren, Armando Santoro, Ewa Paszkiewicz-Kozik, Robin Gasiorowski, Nathalie A Johnson, José S R Oliveira, Valeria Buccheri, Guilherme Fleury Perini, Michael J Dickinson, Andrew Bruce McDonald, Muhit Özcan, Naohiro Sekiguchi, Ying Zhu, Monika Raut, Todd L Saretsky, Akash Nahar, John George Kuruvilla
Quality-of-life analysis of pembrolizumab vs brentuximab vedotin for relapsed/refractory classical Hodgkin lymphoma. Blood advances (2021)
Pietro R Di Ciaccio, Georgia McCaughan, Judith Trotman, Phoebe Joy Ho, Chan Yoon Y Cheah, Shane Gangatharan, Joel Wight, Matthew Ku, Hang Quach, Robin Gasiorowski, Mark N Polizzotto, Henry Miles Prince, Stephen Mulligan, Constantine S Tam, Gareth Gregory, Gregory Hapgood, Andrew Spencer, Michael J Dickinson, Maya Latimer, Anna Johnston, Tasman Armytage, Cindy Lee, Tara Cochrane, Leanne Berkhahn, Robert Weinkove, Richard Doocey, Simon J Harrison, Nicholas Webber, Hui-Peng Lee, Scott Chapman, Belinda A Campbell, Simon D J Gibbs, Nada Hamad
Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic. Internal medicine journal 50 (6) (2020)